Surgery Partners (NASDAQ:SGRY) Sets New 1-Year High – Here’s Why

Surgery Partners, Inc. (NASDAQ:SGRY)’s share price hit a new 52-week high during mid-day trading on Tuesday. The company traded as high as $23.39 and last traded at $23.1910, with a volume of 5,487 shares traded. The stock had previously closed at $23.12.

Key Stories Impacting Surgery Partners

Here are the key news stories impacting Surgery Partners this week:

• Positive Sentiment: Bon Secours acquisition provides valuation support. Bon Secours Mercy Health has agreed to take Surgery Partners private for $23.50 per share, with Bain Capital rolling its equity into the post-merger company. The transaction helps explain why SGRY remains near its 52-week high and above the recently reported consensus price target of $22.61. Surgery Partners stock enters take-private focus after HealthSpan deal
• Neutral Sentiment: Merger investigations could affect the deal outcome. Bleichmar Fonti & Auld and other law firms are investigating whether Surgery Partners’ directors fulfilled their fiduciary duties in connection with the $23.50-per-share merger. These announcements do not allege wrongdoing, but they introduce potential uncertainty around closing terms and timing. SGRY shareholder notice
• Negative Sentiment: TD Cowen downgraded the shares from “strong buy” to “hold.” The downgrade signals that analysts see little additional appreciation beyond the merger consideration at the current trading level. TD Cowen downgrade report
• Negative Sentiment: KeyCorp lowered its earnings outlook. KeyCorp cut its FY2026 EPS forecast to $0.07 from $0.16, reduced FY2027 expectations to a loss of $0.21 per share from a profit of $0.13, and projects losses of $0.13 and $0.08 per share for the third and fourth quarters of 2026, respectively. The revisions contrast with the $0.25 consensus estimate for the current year and point to weaker underlying profitability.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the company. TD Cowen lowered Surgery Partners from a “strong-buy” rating to a “hold” rating in a research report on Saturday. Weiss Ratings upgraded shares of Surgery Partners from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, October 16th. Benchmark reaffirmed a “buy” rating on shares of Surgery Partners in a research note on Tuesday, August 11th. Royal Bank Of Canada lowered shares of Surgery Partners from a “moderate buy” rating to a “hold” rating and set a $23.50 price objective for the company. in a research note on Monday, October 26th. Finally, Raymond James Financial set a $23.50 price objective on shares of Surgery Partners in a research report on Monday, October 26th. Three investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Surgery Partners currently has a consensus rating of “Hold” and an average target price of $20.14.

Surgery Partners Stock Performance

The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.78 and a current ratio of 1.95. The company has a market cap of $3.04 billion, a P/E ratio of -33.12, a P/E/G ratio of 7.19 and a beta of 1.90. The firm has a 50 day moving average price of $15.30 and a 200-day moving average price of $14.68.

Surgery Partners (NASDAQ:SGRY) last posted its earnings results on Monday, August 10th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.04. The firm had revenue of $848.90 million during the quarter, compared to analyst estimates of $830.03 million. Surgery Partners had a positive return on equity of 0.88% and a negative net margin of 2.63%. The company’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same period in the previous year, the company earned $0.17 EPS. On average, research analysts predict that Surgery Partners, Inc. will post 0.25 EPS for the current year.

Insider Buying and Selling at Surgery Partners

In other news, Director Teresa DeLuca acquired 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 18th. The stock was acquired at an average cost of $14.35 per share, with a total value of $143,500.00. Following the acquisition, the director owned 66,843 shares in the company, valued at approximately $959,197.05. This represents a 17.59% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the company. Vise Technologies Inc. acquired a new position in Surgery Partners during the 3rd quarter worth $191,000. State of Wyoming boosted its stake in Surgery Partners by 51.4% during the 3rd quarter. State of Wyoming now owns 23,568 shares of the company’s stock valued at $327,000 after purchasing an additional 7,997 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in Surgery Partners during the 3rd quarter valued at approximately $426,000. Inspire Investing LLC grew its holdings in Surgery Partners by 10.1% in the 3rd quarter. Inspire Investing LLC now owns 44,768 shares of the company’s stock valued at $621,000 after buying an additional 4,099 shares during the last quarter. Finally, TD Waterhouse Canada Inc. increased its position in Surgery Partners by 18.3% in the 3rd quarter. TD Waterhouse Canada Inc. now owns 196,887 shares of the company’s stock worth $2,601,000 after buying an additional 30,476 shares during the period.

Surgery Partners Company Profile

Surgery Partners, Inc is a U.S.-based healthcare services company that operates and manages ambulatory surgery centers and surgical hospitals. The company works with physicians, health systems and other healthcare providers to deliver outpatient surgical care in facilities designed for same-day procedures.

Its facilities provide surgical services across specialties such as orthopedics, pain management, ophthalmology, gastroenterology, urology, gynecology and general surgery. Surgery Partners also supports its operations with clinical, administrative and revenue-cycle services intended to help physicians and facility partners manage patient care and practice operations.

Founded in 2004 and headquartered in Brentwood, Tennessee, Surgery Partners has expanded its platform through acquisitions, joint ventures and other partnerships.